SCHEMBL23778243

SCHEMBL23778243

O=C(O)N1CCCN(C2CCC3(CC2)C(=O)Nc2ncc(Cl)cc23)CC1

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 14/20 0.38
IP6K1 Q92551 6/20 0.38
KCNH2 Q12809 6/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30179222 0.87 MAPK1 (0.41) HRH3IP6K1KCNH2
SCHEMBL20066058 0.87 MAPK1 (0.41) HRH3IP6K1KCNH2
SCHEMBL23778363 0.86 MAP3K11 (0.40) HRH3KCNH2
SCHEMBL23778441 0.82 CALCRL (0.40) HRH3
SCHEMBL23778244 0.81 IP6K1 (0.36) IP6K1
SCHEMBL23778385 0.77 KDM4E (0.41) HRH3
SCHEMBL23778382 0.76 HRH3 (0.39) HRH3IP6K1KCNH2
SCHEMBL20066059 0.75 ALDH1A1 (0.42) HRH3KCNH2
SCHEMBL30179623 0.75 ALDH1A1 (0.42) HRH3KCNH2
SCHEMBL23778450 0.75 OPRM1 (0.48) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3526207-B1 HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. HEPTARES THERAPEUTICS LTD (GB) 2021-09-08 EP claimed
CN-109996792-B Heterocyclic compounds having activity as modulators of muscarinic M1 and/or M4 receptors in the treatment of CNS diseases and pain 赫普泰雅治疗有限公司 2023-02-17 CN disclosed